{"id":"W1992463335","doi":"10.4161/hv.6.4.10867","title":"Development of TNFSF as molecular adjuvants for ALVAC HIV-1 vaccines","year":2010,"lang":"en","type":"article","venue":"Human Vaccines","topic":"HIV Research and Treatment","field":"Immunology and Microbiology","cited_by":15,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"Canadian Institutes of Health Research; Ontario HIV Treatment Network","keywords":"Immunogenicity; Medicine; HIV vaccine; Adjuvant; Vaccination; Clinical trial; Immunology; AIDS Vaccines; Vaccine trial; Virology; Human immunodeficiency virus (HIV); Immune system; Internal medicine","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0001569879,0.0001896828,0.0002943196,0.0001352291,0.0002438694,0.00001045844,0.0002623346,0.0001517045,0.001867905],"category_scores_gemma":[0.0000841705,0.0001504493,0.0001031058,0.00007084539,0.00003407228,0.00005165609,0.00008870576,0.0001593653,0.001131568],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001334026,"about_ca_system_score_gemma":0.0001021695,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001843389,"about_ca_topic_score_gemma":0.0002150954,"domain_scores_codex":[0.9989218,0.00003245299,0.0003277368,0.0002802972,0.00004332145,0.0003944069],"domain_scores_gemma":[0.9993097,0.00006752332,0.00009734794,0.0003264339,0.0001550543,0.00004393057],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0001312701,0.0002546653,0.004317332,0.00005449683,0.0002789875,0.000006736181,0.0003677666,3.928074e-7,0.9761345,0.001691838,0.007559187,0.009202765],"study_design_scores_gemma":[0.003269078,0.0002039793,0.02553253,0.0000248368,0.00003961206,0.00002378188,0.0001050278,5.748508e-7,0.8090677,0.0004424841,0.1611027,0.0001877544],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9968717,0.0006593166,0.0001428821,0.0002003166,0.0002925757,0.0004739941,0.0000544883,0.00005108671,0.001253686],"genre_scores_gemma":[0.9903173,0.0000118056,0.002918447,0.00004295509,0.00004715098,0.0001587828,0.0005122182,0.0000253391,0.005966017],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1670669,"threshold_uncertainty_score":0.9996462,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01878471756305687,"score_gpt":0.3033413365913008,"score_spread":0.2845566190282439,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}